COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,742 Articles (22,502 medRxiv, 8,240 bioRxiv)

Most recent first Previous |  Page 313: Articles 3121-3130  | Next

Mapping COVID-19 vaccine acceptance and uptake amongst Chinese residents: A systematic review and meta-analysis
Masood, H., Irfan, S. A.
10.1101/2023.08.09.23293915 — Posted: 2023-08-17
The CAPP 2 Study Protocol: Strengthening the capacity of healthcare providers to reduce the impact of COVID-19 on African, Caribbean, and Black communities in Ontario.
Etowa, J., Loemba, H., Bailey, L., Yaya, S., Dabone, C., Etowa, E., Ghose, B., Ajiboye, W., Tyerman, J., Luctkar-Flude, M., Rayner, J., Nnorom, O., Taylor, R., Beauchamp, S., Oneka, G., Kohoun, B., Tharao, W., Inoua, H., Edet, R., Kiirya, J., Allibhai, S., Kirunga, K., Kimei, J.
10.1101/2023.08.11.23293990 — Posted: 2023-08-16
Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients with and without history of SARS-CoV-2 infection
Bronder, S., Mihm, J., Urschel, R., Klemis, V., Schmidt, T., Marx, S., Abu-Omar, A., Hielscher, F., Guckelmus, C., Widera, M., Sester, U., Sester, M.
10.1101/2023.08.13.23294045 — Posted: 2023-08-16
Reproduction Number EXCEL Model of COVID-19 for predictive calculation of nearby trend up to the end of infection
Matsuda, S., Toki, H.
10.1101/2023.08.11.23293983 — Posted: 2023-08-16
Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes
Gupta, J. K., Ravindrarajah, R., Tilston, G., Ollier, W., Ashcroft, D. M., Heald, A. H.
10.1101/2023.08.12.23294016 — Posted: 2023-08-16
Predicting subnational incidence of COVID-19 cases and deaths in EU countries
Robert, A., Chapman, L. A., Grah, R., Niehus, R., Sandmann, F. G., Prasse, B., Funk, S., Kucharski, A. J.
10.1101/2023.08.11.23293400 — Posted: 2023-08-16
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Case, B. C., Waksman, O., Rappaport, H., Zhang, C., Waksman, R.
10.1101/2023.08.11.23294002 — Posted: 2023-08-16
Improving estimates of epidemiological quantities by combining reported cases with wastewater data: a statistical framework with applications to COVID-19 in Aotearoa New Zealand
Watson, L. M., Plank, M. J., Armstrong, B., Chapman, J., Hewitt, J., Morris, H., Orsi, A., Bunce, M., Donnelly, C. A., Steyn, N.
10.1101/2023.08.14.23294060 — Posted: 2023-08-16
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period
King, J. P., Chung, J. R., Donahue, J. G., Martin, E. T., Leis, A. M., Monto, A., Gaglani, M., Dunnigan, K., Raiyani, C., Saydeh, S., Flannery, B., Belongia, E. A.
10.1101/2023.08.14.23294086 — Posted: 2023-08-16
A Mixed-Effects Model to Predict COVID-19 Hospitalizations Using Wastewater Surveillance
Daza-Torres, M. L., Montesinos Lopez, J. C., Desai, A. N., Naughton, C. C., Bischel, H. N., Nuno, M.
10.1101/2023.08.14.23293945 — Posted: 2023-08-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).